Cancer Biomarkers

Cancer biomarkers, particular those associated with genetic mutations or epigenetic alterations, often offer a quantitative way to determine when individuals are predisposed to particular types of cancers. A cancer biomarker refers to a substance or process that is indicative of the presence of cancer in the body. A biomarker may be a molecule secreted by a tumor or a specific response of the body to the presence of cancer. Genetic, epigenetic, proteomic, glycomic, and imaging biomarkers can be used for cancer diagnosis, prognosis, and epidemiology.

  • Biomarkers in cancer research
  • Biomarkers in medicine
  • Risk assessment, diagnosis
  • Prognosis and treatment predictions
  • Molecular cancer biomarkers

 

    Related Conference of Cancer Biomarkers

    September 25-26, 2025

    5th World Pathology Conference

    Amsterdam, Netherlands
    December 11-12, 2025

    6th International Conference on Breast Pathology and Cancer Diagnosis

    Amsterdam, Netherlands
    March 26-27, 2026

    24th Annual Pathology Congress

    Dubai, UAE
    June 22-23, 2026

    24th European Pathology Congress

    Paris, France

    Cancer Biomarkers Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in